This review explores how neuroinflammation influences synaptic plasticity, linking it to cognitive dysfunction and emerging therapies.
Synaptic plasticity—the brain’s ability to strengthen, weaken, or reorganize synaptic connections—is essential for learning, memory, and cognitive adaptation. Traditionally studied through mechanisms like long-term potentiation (LTP) and long-term depression (LTD), plasticity has often been viewed in isolation from the brain’s immune system. However, growing evidence reveals that neuroinflammation—a response mediated by microglia, astrocytes, cytokines, and complement proteins—profoundly influences synaptic dynamics across the lifespan.This review examines how neuroinflammation modulates synaptic plasticity under both physiological and pathological conditions. We first describe the cellular and molecular mediators of neuroinflammation and their interactions with core mechanisms of synaptic modulation. Next, we explore how chronic inflammatory signaling impairs synaptic strength, promotes excessive pruning, and alters dendritic spine architecture. These changes are linked to cognitive dysfunction in conditions such as Alzheimer’s disease, multiple sclerosis, major depression, and schizophrenia. Finally, we evaluate emerging therapeutic strategies—including anti-inflammatory drugs, microglial modulators, lifestyle interventions, and precision medicine approaches—aimed at preserving synaptic function and cognitive resilience.By synthesizing current findings, this review highlights neuroinflammation as a central regulator of plasticity and a promising target for interventions that restore neural health across a range of neurodegenerative and neuropsychiatric disorders.
No takes yet. Share an insight, caveat, or question.
J. Hughlings Jackson (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: